Noticias de AKBA_US

Noticias del mercado

Últimas noticias sobre AKBA_US — 158 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AKBA_US ✕ 158 resultados
07/04/2026 AKBA_US — MarketBeat
BTIG Research Reaffirms "Buy" Rating for Akebia Therapeutics (NASDAQ:AKBA)
07/04/2026 AKBA_US — MarketScreener
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
06/04/2026 AKBA_US — Bitget ES ← EN
Akebia Therapeutics llevará a cabo reuniones de inversores en el Simposio de innovación biotecnológica Raymond James 2026
04/04/2026 AKBA_US — Seeking Alpha
Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day - Slideshow (NASDAQ:AKBA) 2026-04-04
03/04/2026 AKBA_US — sonla.gov.vn
AKBA Q4 2025 Earnings: Akebia Therapeutics Inc. misses EPS estimates, no revenue
03/04/2026 AKBA_US — DirectorsTalk Interviews
Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Potential Upside of Over 218% with a Focus on Kidney Disease Treatments
03/04/2026 AKBA_US — Stock Titan
Akebia (AKBA) director granted 214,400 options at $1.41, 3-year vest
03/04/2026 AKBA_US — Stock Titan
Akebia (NASDAQ: AKBA) director Philip J. Vickers files initial Form 3
02/04/2026 AKBA_US — Yahoo Finance
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/04/2026 AKBA_US — GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/04/2026 AKBA_US — GlobeNewswire ES ← EN
Akebia Therapeutics informa subvenciones de incentivo según la regla de cotización en Nasdaq 5635(c)(4)
02/04/2026 AKBA_US — Yahoo Finance
Akebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets
02/04/2026 AKBA_US — Stock Titan
Akebia gives 13 new hires stock options for 679,900 shares
02/04/2026 AKBA_US — MarketBeat
Akebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets
02/04/2026 AKBA_US — Investing.com
Akebia Therapeutics adds Philip Vickers to board of directors By Investing.com
02/04/2026 AKBA_US — Investing.com ES ← EN
Akebia Therapeutics incorpora a Philip Vickers a la junta directiva Por Investing.com
01/04/2026 AKBA_US — Yahoo Finance
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
01/04/2026 AKBA_US — GlobeNewswire
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
01/04/2026 AKBA_US — Stock Titan
Akebia brings in ex-Shire R&D chief as it weighs rare kidney assets
01/04/2026 AKBA_US — Investing.com
Akebia Therapeutics adds Philip Vickers to board of directors

Página 6 de 8

keyboard_arrow_up